BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Approvals (World)
Bristol-Myers Squibb Company (BMY) Release: ELIQUIS Approved For Treatment Of Venous thromboembolic events (Deep Vein Thrombosis [DVT], Pulmonary Embolism [PE]) and prevention of recurrent DVT and PE 11/26/2014
Once-Weekly Eli Lilly (LLY) Diabetes Drug Wins FDA Approval 11/26/2014
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s Rezolsta 11/25/2014
Ariad Pharmaceuticals, Inc. (ARIA) And Specialised Therapeutics Australia Announce Approval Of Iclusig (Ponatinib) In Australia 11/24/2014
Novartis AG (NVS) Drug Signifor Approved In EU, Marking An Advance For Patients With Inadequately Controlled Acromegaly 11/24/2014
Health Canada Approves IMBRUVICA By Priority Review, Giving Physicians And Patients A Much-Needed Option In The Fight Against Chronic Lymphocytic Leukemia 11/19/2014
Celgene (CELG) Announces Swissmedic Approval Of REVLIMID® (Lenalidomide) For Treatment Of Patients With Relapsed Or Refractory 11/18/2014
FDA Approves Roche (RHHBY)’s Avastin Plus Chemotherapy To Treat Women With Platinumresistant Recurrent Ovarian Cancer 11/17/2014
pSivida Corp (PSDV) Reports ILUVIEN® Granted Marketing Authorization In Belgium 11/12/2014
Dr. Reddy's Laboratories Ltd. (RDY) Wins FDA Approval For Roche (RHHBY) Drug Generic 11/7/2014
Glenmark Generics Receives Final ANDA Approval For Omeprazole DR Capsules 11/5/2014
Vectura Group plc (VEC.L) Approval In Baltics For Innovative Respiratory Inhaler AirFluSal® Forspiro® 11/4/2014
Admedus Cardiocel® Gains Special Access In Singapore 11/3/2014
FDA Panel Backs Daiichi Sankyo, Inc. (4568.t)'s New A-Fib Drug Savaysa 10/31/2014
AstraZeneca PLC (AZN) Wins FDA Approval For Two-In-One Diabetes Pill 10/31/2014
TWi Pharmaceuticals, Inc. Receives U.S. FDA Approval On Generic Donepezil Hydrochloride Tablets USP, 23 Mg, Its Fifth ANDA From U.S. FDA 10/30/2014
Europe Approves Clinuvel's Novel Australian Drug Developed For Rare Sun Disease 10/24/2014
AstraZeneca PLC (AZN)'s Cancer Drug Pipeline Gets Boost From European Green Light 10/24/2014
Ferring Pharmaceuticals: CORTIMENT® MMX®, A New Treatment For Ulcerative Colitis, Receives European Approval 10/22/2014
Santen Announces Positive Outcome Of The European Decentralized Procedure For Approval Of TAPTIQOM® 10/22/2014
China Biologic Products Awarded CFDA Approval To Manufacture Plasma Product 10/20/2014
Pharmacyclics, Inc. (PCYC) Release: IMBRUVICA® (ibrutinib) Now Approved In Europe for Treatment Of Two Blood Cancers 10/17/2014
Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev 10/17/2014
InterMune, Inc. (ITMN) Wins FDA Approval For Lung Drug At Center Of Roche (RHHBY) Deal 10/17/2014
ViiV Healthcare Receives Approval For Triumeq™ (dolutegravir/abacavir/lamivudine), In Canada - A New Once-Daily Single-Pill Regimen For The Treatment Of HIV 10/14/2014
Eisai Inc. (ESALF.PK) Grabs FDA Approval For Chemotherapy Side Effect Drug AKYNZEO® 10/13/2014
FDA Approves Eisai Inc. (ESALF.PK) Drug For Chemotherapy-Associated Nausea 10/10/2014
Novartis AG (NVS) Release: (Pr)Lucentis® (ranibizumab) Approved By Health Canada To Treat Vision Loss Resulting From Choroidal Neovascularization In Pathologic Myopia (mCNV)(1) 10/8/2014
Ganeden Biotech Release: GanedenBC30 Probiotic Approved In Japan, Taiwan, India & Philippines 10/6/2014
Celgene (CELG) Announces The Swissmedic Approval Of ABRAXANE® For Treatment Of Both Metastatic Pancreatic And Breast Cancers 9/25/2014
EPIRUS’ Remicade® Biosimilar Receives Final Approvals In India 9/16/2014
ThromboGenics NV (TBGNF)' JETREA® Gains Approval In South Korea 9/8/2014
China’s Food And Drug Administration Has Cleared NovaBay Pharmaceuticals, Inc. (NBY)’s Neutrophase Skin And Wound Cleanser For Sale Throughout Mainland China By NovoBay’s Partner, China Pioneer Pharma 9/3/2014
New Indication For VIMPAT® (Lacosamide): UCB Group (UCBJF.PK)'s Anti-Epileptic Drug Approved By FDA As Monotherapy In The Treatment Of Patients With Partial-Onset Seizures 9/2/2014
GE Healthcare Announces European Union Approval Of VIZAMYL™ (Flutemetamol (18F) Solution For Injection) For PET Imaging Of Beta Amyloid Plaque In Suspected Alzheimer’s Disease 9/2/2014
TWi Pharmaceuticals, Inc. Receives FDA Final Approval On Generic Megestrol Acetate 125mg/Ml Oral Suspension 8/28/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: Health Canada Approves Eloctate™, The First Therapy To Extend The Interval Between Prophylactic Infusions In Hemophilia A 8/26/2014
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE)'s ViiV Healthcare Wins Approval For HIV Combo Drug 8/25/2014
GlaxoSmithKline (GSK)'s Asthma Treatment Wins FDA Approval 8/21/2014
Amerigen Pharmaceuticals Announces That Its Chinese Subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., Has Received Chinese FDA (CFDA) Approval And Has Subsequently Launched Its Generic Mecobalamin 0.5 Mg Tablets Into The China Domestic Market 8/20/2014
NanoString Technologies Inc. (NSTG) Receives Market Approval From The Australian Therapeutic Goods Administration For Its Prosigna Breast Cancer Prognostic Gene Signature Assay 8/6/2014
Health Canada Approves Celgene Corporation (CELG)'s ABRAXANE® Plus Gemcitabine For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 8/6/2014
European Commission (EC) Approves Roche (RHHBY)’s Avastin For Platinum-Resistant Recurrent Ovarian Cancer 8/6/2014
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients 8/1/2014
Vertex Pharmaceuticals Incorporated (VRTX) Receives European Approval For KALYDECO™ (ivacaftor) In Eight Non-G551D Gating Mutations 8/1/2014
FDA Green Lights Boehringer Ingelheim Corporation, Eli Lilly and Company (LLY)'s Jardiance For Type 2 Diabetes 8/1/2014
Roche (RHHBY)’s Gazyvaro Approved In Europe For Patients With The Most Common Type Of Leukemia 7/29/2014
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval Of IMBRUVICA® (Ibrutinib) For Treatment Of Two Blood Cancers 7/25/2014
Biogen Idec, Inc. (Massachusetts) (BIIB) Release: PLEGRIDY™ (Peginterferon beta-1a) Approved In The European Union For The Treatment Of Multiple Sclerosis 7/24/2014
Health Canada Approves Kane Biotech Inc. (KNE)'s DispersinB® For Human Use 7/23/2014
Starpharma: VivaGel® Condom Receives TGA Device Certification - Launch Preparations To Follow 7/21/2014
Hamilton Thorne, Inc. Receives Notification Of Grant Of Patent Right And CFDA Approval To Market Its LYKOS(R) Laser System In China 7/16/2014
MediWound (MDWD) Announces NexoBrid Marketing Approval From Israeli Ministry of Health 7/16/2014
Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval Of APTIOM(TM) (eslicarbazepine acetate) As A Once-Daily Adjunctive Treatment For Partial-Onset Seizures In Patients With Epilepsy 7/11/2014
Can-Fite BioPharma (CFBI)'s CF102 Approved For Compassionate Use In Israel For Liver Cancer Patient 7/10/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: Swissmedic Approves AMITIZA® (Lubiprostone) For The Treatment Of Opioid-Induced Constipation 7/8/2014
Bayer Inc. Release: Nexavar® (sorafenib tablets) Now Approved In Canada For The Treatment Of Differentiated Thyroid Cancer 7/7/2014
Japan Becomes First Country To Approve Roche (RHHBY)'s Alectinib For People With A Specific Form Of Advanced Lung Cancer 7/7/2014
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIM™ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014
Bristol-Myers Squibb Company (BMY) Release: Japan Approves First All-Oral, Interferon- And Ribavirin-Free Hepatitis C Treatment, Daklinza® (Daclatasvir) And Sunvepra®(Asunaprevir) Dual Regimen 7/7/2014
Theravance, Inc. (THRX) Release: Anoro® Ellipta® (Umeclidinium/Vilanterol) Gains Approval In Japan For The Treatment Of COPD 7/7/2014
FDA Approves Novo Nordisk A/S (NVO)'s NovoSeven® RT To Treat Glanzmann's Thrombasthenia (GT) With Refractoriness 7/7/2014
Flamel Technologies (FLML) Wins FDA Approval For VAZCULEP 6/30/2014
pSivida Corp (PSDV)'s Iluvien Gets Marketing Authorizations In 10 More EU Countries 6/30/2014
India's Ranbaxy Laboratories (RANBAXY.BO) Wins FDA Approval For Novartis AG (NVS)'s Diovan Generic 6/27/2014
NeuroMetrix, Inc. (NURO) Reports Japan Regulatory Approval For NC-stat DPNCheck 6/24/2014
Hengrui Medicine Granted Approval To Market Cancer Drug In U.S. 6/24/2014
Roche (RHHBY) Medicine Gazyvaro Granted Approval For The Therapy Of Patients With Previously Untreated Chronic Lymphocytic Leukemia And Co-Existing Medical Conditions In Switzerland 6/18/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In Europe For The Prevention Of Anal Cancer 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA): FDA Clears Expanded Label For AZILECT® For Treatment Across All Stages Of Parkinson's Disease 6/9/2014
Boehringer Ingelheim Corporation's Pradaxa® Wins EU Approval To Treat Deep Vein Thrombosis And Pulmonary Embolisms 6/6/2014
Janssen-Cilag International NV Release: INVEGA® Receives European Commission Approval To Extend Its Adult Indication For Treatment Of Schizophrenia To Include Adolescents Aged 15 Years And Older 6/4/2014
Bayer HealthCare (BAY) Receives EU Approval For Nexavar (Sorafenib) For The Treatment Of Differentiated Thyroid Cancer 5/30/2014
FDA Green Lights Eisai Inc. (ESALF.PK)'s ALOXI ®To Prevent Nausea And Vomiting Due To Chemotherapy In Kids 5/29/2014
Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Approval For QVAR® 5/27/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Entyvio Wins FDA Approval For Severe Colitis 5/22/2014
Novartis AG (NVS) Release: First Myelofibrosis Medication For Life-Threatening Blood Cancer Approved In Singapore 5/15/2014
Actavis (ACT) Receives Final Approval For Generic Version Of Exalgo® 5/14/2014
Perrigo Company (PRGO) Announces FDA Approval Of Generic Version Of Astepro® Nasal Spray 5/12/2014
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s SYNRIBO® For Injection For Home Administration 5/5/2014
FDA Approves Ibalizumab Manufactured By WuXi PharmaTech Co., Ltd. For Treatment Of Patients On Expanded Access 5/5/2014
Apricus Biosciences (APRI) Announces National Phase Approval For Vitaros® In Spain 4/24/2014
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Wins FDA Approval For Arzerra As First-Line Treatment For Chronic Lymphocytic Leukaemia (CLL) 4/18/2014
FDA Approves GlaxoSmithKline (GSK)'s Tanzeum To Treat Type 2 Diabetes 4/15/2014
Teva Pharmaceutical Industries Limited (TEVA) First Approval And Launch Of Generic Lovaza® Capsules In The United States 4/8/2014
Sanofi Pasteur (SASY.PA) Release: Gardasil® Approved In The European Union For A 2-Dose Schedule In Children Aged From 9 To 13 Years 4/7/2014
Stallergenes, S.A. (GENP.PA) Wins FDA's Go-Ahead For Oralair Allergy Pill 4/2/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Gets Approval For Influenza Vaccines 3/31/2014
Swedish Orphan Biovitrum: FDA Approves Alprolix™ 3/31/2014
GlaxoSmithKline (GSK)'s Type 2 Diabetes Drug Eperzan® Wins EU Approval 3/27/2014
Actavis (ACT) And Valeant Pharmaceuticals International (VRX) Announce FDA Approval For Metronidazole 1.3% 3/26/2014
Astellas Pharma Inc. (ALPMY) Announces Marketing Approval In Japan For XTANDI® (Enzalutamide) Capsules, An Advanced Prostate Cancer Treatment 3/25/2014
Otsuka Pharmaceutical Co., Ltd.'s Samsca® Approved In Japan As The World's First Drug Therapy For ADPKD, A Rare Kidney Disease 3/24/2014
Medivir AB (MVRBF): Simeprevir Has Now Been Approved In Russia 3/24/2014
Pierre Fabre Obtains FDA Approval To Market Hemangeo™ For The Treatment Of Infantile Hemangioma 3/18/2014
Starpharma Holdings Ltd Release: Vivagel®-Coated Condom Approved For Marketing In Japan 3/14/2014
TaiGen Biotechnology Granted Taiwanese Approval For Novel Antibiotic 3/13/2014
Northwest Biotherapeutics (NWBO) Jumps As Germany Permits Sale Of Brain Cancer Drug 3/11/2014
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) Now Approved In Over 100 Countries For Stroke Prevention In Atrial Fibrillation 3/6/2014
Vectura Group plc (VEC.L): South Korean Regulatory Authority Confirm Approval Of AirFluSal® Forspiro® 2/28/2014
Oasmia Wins FDA Conditional Approval For Paccal Vet In Two Canine Cancers 2/28/2014
BioDiem Ltd. (BDM.AX)'s Announcement Of Approval Of LAIV Seasonal Flu Vaccine In India 2/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Full FDA Approval Of SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 2/13/2014
The Otsuka Pharmaceutical Co., Ltd. And H. Lundbeck A/S (LUN.CO) Alliance Announces Once-Monthly (Pr)ABILIFY MAINTENA(™) (ARIPIPRAZOLE For Prolonged Release Injectable Suspension)1 Now Approved In Canada For The Maintenance Treatment Of Schizophrenia In Stabilized Adult Patients 2/13/2014
Vectura Group plc (VEC.L) Release: Norwegian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 2/10/2014
Genzyme Corporation (GENZ)’s Lemtrada® Approved In Mexico For Treatment Of Multiple Sclerosis 2/4/2014
Perrigo Company (PRGO) Receives FDA Final Approval For Generic Equivalent To Prandin® 1/24/2014
Miltenyi Biotec, Inc. Receives FDA Approval For Clinimacs® CD34 Reagent System For Prevention Of Graft-Versus-Host Disease In The Treatment Of Acute Myeloid Leukemia 1/24/2014
AstraZeneca PLC (AZN)'s Diabetes Drug Xigduo Approved In Europe 1/23/2014
Apricus Biosciences (APRI)Announces National Phase Approval For Erectile Dysfunction Cream - Vitaros® In Belgium 1/23/2014
Aegerion Pharmaceuticals, Inc. (AEGR)'s JUXTAPID® Capsules Approved In Mexico 1/20/2014
Keryx Biopharmaceuticals (KERX) Announces Marketing Approval Of Ferric Citrate In Japan 1/17/2014
Vectura Group plc (VEC.L) Hungarian Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/16/2014
Vectura Group plc (VEC.L) German Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 1/13/2014
GlaxoSmithKline (GSK) Gains Accelerated FDA Approval For Combination Use Of Mekinist® (Trametinib) And Tafinlar® (Dabrafenib) 1/9/2014
Celgene International Sárl (CELG) Release: ABRAXANE® Plus Gemcitabine Receives European Marketing Authorization For First-Line Treatment Of Patients With Metastatic Pancreatic Cancer 1/7/2014
Lundbeck Inc. (LUN.CO) Wins EU Marketing Approval For Brintellix To Treat Adult Depression 1/3/2014
Actelion Ltd. (ALIOF.PK)'s New Blood Pressure Drug Get EU Nod 12/23/2013
Biota Pharmaceuticals, Inc. Reports That Laninamivir Octanoate Is Approved For The Prevention Of Influenza In Japan 12/23/2013
Kanghong Pharma Gains CFDA Approval For China's First Innovative MAb 12/23/2013
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s Second Lung Drug ANORO™ ELLIPTA™ Wins FDA Approval 12/20/2013
Vectura Group plc (VEC.L): Danish Regulatory Authority Confirm Approval Of Airflusal® Forspiro® 12/18/2013
AstraZeneca PLC (AZN)'s Fluenz Tetra Gets European Marketing Grant 12/6/2013
European Medicines Agency Approves Once Every Two Weeks Dosing Option For CSL Behring UK Ltd's Hizentra® (Human Normal Immunoglobulin, SCIg) 12/5/2013
Fresenius Medical Care's Velphoro® (PA21) Receives FDA Approval 12/2/2013
GW Pharmaceuticals Announces Sativex® Regulatory Approval In Switzerland 11/27/2013
Mylan Inc. (MYL)-BioCon Limited (BIOCON.NS) Receive First Indian Biosimilar Regulatory Approval For Herceptin® 11/26/2013
BTG plc (BTG.L) Surges As Varicose Vein Treatment Grabs FDA Approval; Stock Up +13.75% At Market Close (November 26, 2013) 11/26/2013
Janssen-Cilag International NV (JNJ)'s INVOKANA™ Wins Approval In The EU For Type 2 Diabetes Patients 11/26/2013
GlaxoSmithKline (GSK)'s Pioneering Bird Flu Vaccine Gets FFA Sciences Approval 11/25/2013
Bavarian Nordic (BAVA.CO) Receives Health Canada Approval Of IMVAMUNE Smallpox Vaccine 11/22/2013
EU Approves Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S (LUN.CO)'s Once-Monthly Abilify Maintena® For Schizophrenia 11/21/2013
Swedish Orphan Biovitrum Receives Approval For Kineret® For Treatment Of Rare Disease CAPS 11/20/2013
EU Approval For Bayer AG (BAYN.DE)'s Prostate Cancer Drug 11/19/2013
GlaxoSmithKline (GSK)'s Asthma Drug Relvar Approved In Europe 11/18/2013
Bayer HealthCare (BAY) Receives Approval For Xofigo® (radium Ra 223 dichloride) Injection In Europe 11/15/2013
Hong Kong Authority Approves Mundipharma AG's Flutiform® (fluticasone propionate/formoterol fumarate), a New Treatment for Asthma 11/8/2013
Lupin Ltd. (LUPN.BO) Receives FDA Approval for its New Drug Application for Antara® Capsules 10/23/2013
Basilea Pharmaceutica (BSLN.SW): Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia 10/23/2013
Boehringer Ingelheim Corporation's New Once-Daily Striverdi* (Olodaterol) Respimat® Gains Approval in First EU Countries 10/18/2013
Novo Nordisk Canada Inc. (NVO) Release: Health Canada Approves Levemir® Flextouch® Prefilled Insulin Pen for the Treatment of Type 1 and Type 2 Diabetes 10/18/2013
UCB Group (UCBJF.PK)'s Cimzia® (Certolizumab Pegol) Approved by FDA for Treatment of Adults With Active Ankylosing Spondylitis 10/18/2013
Novo Nordisk A/S (NVO)'s Novoeight Wins FDA Approval for Hemophilia A 10/16/2013
Teva Pharmaceutical Industries Limited (TEVA) Announces FDA Approval of Generic TOBI® in the United States 10/14/2013
FDA Approves Sanofi (France) (SAN.PA)'s Nasacort® Allergy 24HR for Over-the-Counter Use 10/11/2013
Lundbeck Inc. (LUN.CO), Takeda Pharmaceutical Co. Ltd. (TKPYY)'s Win FDA Approval for Depression Drug 10/1/2013
UCB, Inc. (UCBJF.PK)'s Cimzia® Wins FDA Approval for Psoriatic Arthritis 9/30/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in South Africa 9/30/2013
CSL Behring Gains Approval to License Hizentra® in Japan for the Treatment of Primary Immunodeficiency and Secondary Immunodeficiency 9/27/2013
Medivir AB (MVIRb.F)'s Simeprevir Has Been Approved in Japan for the Treatment of Genotype 1 Chronic Hepatitis C Infection 9/27/2013
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)' Tybost™, a New Boosting Agent for HIV Therapy 9/26/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013
Cardiome Pharma Corp. (COM.TO) Receives Approval for BRINAVESS™ in Turkey 9/25/2013
Abstral® , Manufactured and Packaged by Recipharm AB for Kyowa Hakko Kirin, Has Been Approved in Japan 9/23/2013
Sosei Group Corporation's First in Class Once-Daily Dual Bronchodilator Ultibro® Breezhaler® (QVA149) Approved for the Treatment of COPD in Europe 9/23/2013
Orexo AB Announces the Approval of Abstral® in Japan 9/20/2013
Vectura Group plc (VEC.L) Release: Approval of Once-Daily Dual Bronchodilator Ultibro® Inhalation Capsules in Japan (QVA149) for the Treatment of COPD 9/20/2013
Sosei Group Corporation: First in Class Once-Daily Dual Bronchodilator Ultibro Inhalation Capsules (QVA149) Approved for the Treatment of COPD in Japan 9/20/2013
GlaxoSmithKline (GSK), Theravance, Inc. (THRX)'s RELVAR™ ELLIPTA™Gains Approval in Japan for the Treatment of Asthma 9/20/2013
Skyepharma PLC (SKYEF) Release: Flutiform® Approved in Japan 9/20/2013
Four-Strain AstraZeneca PLC (AZN) Flu Vaccine Wins EU Green Light 9/20/2013
Huahai Pharma China-Approved to Produce AIDS Treatment 9/18/2013
European Commission (EC) Approves Genzyme Corporation (GENZ)'s Multiple Sclerosis Treatment Lemtrada™ (alemtuzumab) 9/17/2013
Dr. Reddy's Laboratories Ltd. (RDY)'s Announces the Approval of Azacitidine for Injection 9/17/2013
FDA Approves Teva Pharmaceutical Industries Limited (TEVA)'s Generic Version of Roche (RHHBY)'s Xeloda 9/17/2013
Alexion Pharmaceuticals Inc. (ALXN)'s Soliris® (eculizumab) Receives Marketing Approval in Japan for All Patients With aHUS 9/13/2013
Medigus (MDGS.TA) Announces Marketing Approval From the Israeli Ministry of Health (MEA) for SRS™ System for the Treatment of Gastroesophageal Reflux Disease (GERD) 9/12/2013
Bayer AG (BAYN.DE)'s Stivarga® (regorafenib) Tablets Approved in Europe 8/30/2013
European Commission (EC) Approves Genzyme Corporation (GENZ)’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) 8/30/2013
Zhejiang Beta's Conmana, a Cancer Drug, is a Big Winner 8/26/2013
Bayer AG (BAYN.DE)'s Stivarga Approved for Further Indication in Japan 8/21/2013
Alcon Canada Receives Approval for JETREA™ (Ocriplasmin) Solution for Intravitreal Injection, the First and Only Eye Medicine to Treat Sight-Threatening, Symptomatic Vitreomacular Adhesion 8/16/2013
Additional GlaxoSmithKline (GSK) Quadrivalent Intramuscular Influenza Vaccine Approved by FDA 8/16/2013
FDA Approves GlaxoSmithKline (GSK)'s HIV Drug 8/14/2013
Cosmederm Gains CFDA Approval for Topical Skin Treatment 8/12/2013
Celgene International Sárl (CELG)'s Oral Anti-Cancer Therapy Pomalidomide Gets European Commission (EC) Approval 8/9/2013
European Commission (EC) Approves Janssen-Cilag International NV (JNJ)'s VELCADE® as a Frontline Induction Therapy Before Stem Cell Transplantation 8/8/2013
Zoetis (ZTS) Joint Venture in China Receives Approval for Rui Lan An™ Swine Vaccine Against PRRS 8/5/2013
FDA Expands Age Indication for Novartis AG (NVS)'s Menveo®, First and Only Quadrivalent Meningococcal Vaccine for Infants as Young as 2 Months of Age[1] 8/2/2013
Takeda Pharmaceutical Co. Ltd. (TKPYY)'s DPP-4 Treatment for Type 2 Diabetes Approved in China 8/1/2013
RaySearch Laboratories Receives Chinese Regulatory Approval for RayStation® 7/26/2013
Warner Chilcott, PLC (WCRX) Announces FDA Approval of New Oral Contraceptive 7/25/2013
GlaxoSmithKline (GSK) Release: Tafinlar™ and Mekinist™ Approved in Canada for Metastatic Melanoma 7/24/2013
Novaliq GmbH Announces European Market Approval for NovaTears™ OTC 7/23/2013
Pfizer Inc. (PFE)'s Arthritis Drug Xeljanz Approved in Switzerland, Argentina, Kuwait, United Arab Emirates 7/15/2013
Roche (RHHBY) Wins Conditional EU Approval for Cancer Drug Erivedge 7/15/2013
TGA of Australia Approves Vertex Pharmaceuticals (MA) (VRTX)'s KALYDECO for Cystic Fbrosis 7/10/2013
FDA Approves Orexo AB's New Drug to Fight Opioid Addiction 7/9/2013
Cell Therapeutics, Inc. (CTIC) Release: Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI™ (pixantrone) 7/8/2013
FDA OKs Hisamitsu Pharmaceutical's First Nonhormonal Drug for Hot Flashes 7/2/2013
Sanofi (France) (SAN.PA)'s Diabetes Treatment Lyxumia Approved in Japan 6/28/2013
FDA Approves Teva Pharmaceutical Industries Limited (TEVA) Drug as First OTC Morning After Pill, Lifts Age Limit 6/21/2013
Roche (RHHBY)'s Avastin Approved in Japan for Treatment of Aggressive Brain Cancer 6/18/2013
Apricus Biosciences (APRI) Receives European Approval for Vitaros® for the Treatment of Erectile Dysfunction 6/10/2013
FDA Approves Sanofi Pasteur (SASY.PA) Influenza Vaccine 6/10/2013
FDA OKs Flamel Technologies (FLML)' Bloxiverz 6/3/2013
FDA Approves Two GlaxoSmithKline (GSK) Melanoma Drugs 5/31/2013
European Commission (EC) Approves Gilead Sciences, Inc. (GILD)'s Stribild as Single Tablet Regimen for HIV-1 Treatment 5/28/2013
GlaxoSmithKline (GSK)'s BREO™ ELLIPTA™ Receives Regulatory Approval in U.S. 5/13/2013
FDA OKs Novartis AG (NVS) Drug for a Form of Childhood Arthritis 5/13/2013